Shulou(Shulou.com)11/24 Report--

Thanks to CTOnews.com netizens for the delivery of clues about the past, rain and snow! CTOnews.com, June 30, according to the website of the State intellectual property Office, Huawei Technology Co., Ltd. today announced a patent for "a brain-computer interface device and information acquisition method" under the application number CN116350174A.

The summary shows that this new patent relates to the field of the Internet of things, and the brain-computer interface includes a light source, a time-domain delay module, a wavelength-dependent splitter module, a sensor network and a sensor front-end. Among them, the light source is used to provide broad-spectrum pulse light train, the time-domain delay module is used to convert the wide-spectrum pulse light train into multi-wave pulse light train, and the wavelength correlation splitting module is used to decompose the multi-wave pulse light train into sparse pulse light train. The sensor network is used to send the sparse pulse light train to the sensing point of the sensor front end, and the sensor front end is used to send the sparse pulse light train to the target brain through the sensing point to obtain sensing information.

▲ schematic diagram of Huawei's new patent according to Huawei, the patent obtains different wavelengths of probe light by using "broad-spectrum pulsed light and time-domain delay technology", without setting multiple light sources or adding corresponding wavelength control modules, thus achieving high spatial resolution of the brain-computer interface on the basis of "ensuring the small integration of the brain-computer interface".

▲ image source Neuralink official website brain-computer interface is another hot science and technology field in recent years, and many companies at home and abroad have carried out related research, among which Neuralink, a brain-computer interface startup company of Elon Musk, has made rapid progress.

As previously reported by CTOnews.com, Musk revealed at the VivaTech event in Paris that Neuralink plans to conduct its first human trial this year, and the company plans to implant a device into a tetraplegic or amputated patient.

Last month, Neuralink said it had obtained approval from the US Food and Drug Administration (FDA) for human clinical trials, which was also confirmed by FDA, but the agency declined to give further details.

Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.